Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,660 | -40,855 | -21,717 | -14,293 | -8,474 |
| Depreciation Amortization | 136 | 233 | 110 | 0 | 0 |
| Accounts payable and accrued liabilities | 853 | -90 | 728 | 569 | 1,436 |
| Other Working Capital | -5,805 | 4,475 | -577 | -593 | 915 |
| Other Operating Activity | 1,288 | 10,527 | 3,275 | 2,029 | -247 |
| Operating Cash Flow | $-13,189 | $-25,710 | $-18,181 | $-12,288 | $-6,369 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25,000 | 25,000 | N/A | N/A |
| Debt Repayment | -21 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,589 | 10,008 | 30 | 30 | 8 |
| Other Financing Activity | 0 | -720 | -449 | 0 | 0 |
| Financing Cash Flow | $4,568 | $34,287 | $24,581 | $30 | $8 |
| Beginning Cash Position | 73,820 | 65,243 | 65,243 | 65,243 | 65,243 |
| End Cash Position | 65,199 | 73,820 | 71,642 | 52,985 | 58,881 |
| Net Cash Flow | $-8,621 | $8,578 | $6,400 | $-12,258 | $-6,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,189 | -25,710 | -18,181 | -12,288 | -6,369 |
| Free Cash Flow | -13,189 | -25,710 | -18,181 | -12,288 | -6,369 |